
Kristin Ann Vajda
Examiner (ID: 10363, Phone: (571)270-5232 , Office: P/1626 )
| Most Active Art Unit | 1622 |
| Art Unit(s) | 4131, 1622, 1626 |
| Total Applications | 2296 |
| Issued Applications | 1831 |
| Pending Applications | 129 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18213600
[patent_doc_number] => 20230059865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => METHODS AND COMPOSITIONS FOR MODULATING SPLICING
[patent_app_type] => utility
[patent_app_number] => 17/502824
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 140025
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 383
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502824
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/502824 | Methods and compositions for modulating splicing | Oct 14, 2021 | Issued |
Array
(
[id] => 17851827
[patent_doc_number] => 20220281869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/490482
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17490482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/490482 | Purinones as ubiquitin-specific protease 1 inhibitors | Sep 29, 2021 | Issued |
Array
(
[id] => 18844466
[patent_doc_number] => 20230406870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => PROCESS FOR PREPARING DIMERIC PHOSPHAZENE DERIVED BRONSTED ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/030728
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030728
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/030728 | Process for preparing dimeric phosphazene derived BrOnsted acids | Sep 27, 2021 | Issued |
Array
(
[id] => 17473961
[patent_doc_number] => 20220081465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => C7 SUBSTITUTED OXYSTEROLS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/476153
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17476153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/476153 | C7 substituted oxysterols and methods of use thereof | Sep 14, 2021 | Issued |
Array
(
[id] => 18739513
[patent_doc_number] => 20230348450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/025847
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22686
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025847
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025847 | CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE | Sep 13, 2021 | Pending |
Array
(
[id] => 20213505
[patent_doc_number] => 12410147
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Surfactants
[patent_app_type] => utility
[patent_app_number] => 18/043178
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6168
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043178
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043178 | Surfactants | Sep 2, 2021 | Issued |
Array
(
[id] => 17311911
[patent_doc_number] => 20210400959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => DISINFECTING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/462131
[patent_app_country] => US
[patent_app_date] => 2021-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17462131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/462131 | Disinfecting composition | Aug 30, 2021 | Issued |
Array
(
[id] => 17343576
[patent_doc_number] => 20220009907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METALLOENZYME INHIBITOR COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/462909
[patent_app_country] => US
[patent_app_date] => 2021-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17462909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/462909 | Metalloenzyme inhibitor compounds | Aug 30, 2021 | Issued |
Array
(
[id] => 19165931
[patent_doc_number] => 11981820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Ultra bright dimeric or polymeric dyes
[patent_app_type] => utility
[patent_app_number] => 17/458938
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14983
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 316
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458938
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/458938 | Ultra bright dimeric or polymeric dyes | Aug 26, 2021 | Issued |
Array
(
[id] => 17315981
[patent_doc_number] => 20210405029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMPOUNDS INHIBITING NEF-CALNEXIN INTERACTION
[patent_app_type] => utility
[patent_app_number] => 17/410882
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13146
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410882
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/410882 | Compounds inhibiting Nef-calnexin interaction | Aug 23, 2021 | Issued |
Array
(
[id] => 19701642
[patent_doc_number] => 12195654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Luminescent particle and compound
[patent_app_type] => utility
[patent_app_number] => 17/407146
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 15127
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17407146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/407146 | Luminescent particle and compound | Aug 18, 2021 | Issued |
Array
(
[id] => 17829982
[patent_doc_number] => 20220267286
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2022-08-25
[patent_title] => 2-THIOXOTHIAZOLIDIN-4-ONE DERIVATIVES ACTIVE AS TRANSTHYRETIN LIGANDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/405506
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405506
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/405506 | 2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof | Aug 17, 2021 | Issued |
Array
(
[id] => 17533550
[patent_doc_number] => 20220112159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME
[patent_app_type] => utility
[patent_app_number] => 17/405989
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405989
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/405989 | Sulfonylureas and related compounds and use of same | Aug 17, 2021 | Abandoned |
Array
(
[id] => 17829982
[patent_doc_number] => 20220267286
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2022-08-25
[patent_title] => 2-THIOXOTHIAZOLIDIN-4-ONE DERIVATIVES ACTIVE AS TRANSTHYRETIN LIGANDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/405506
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405506
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/405506 | 2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof | Aug 17, 2021 | Issued |
Array
(
[id] => 17258432
[patent_doc_number] => 20210371417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/396312
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -123
[patent_words_short_claim] => 376
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396312
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/396312 | AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS | Aug 5, 2021 | Abandoned |
Array
(
[id] => 18428645
[patent_doc_number] => 11673855
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-13
[patent_title] => Voltage gated sodium channel imaging agents
[patent_app_type] => utility
[patent_app_number] => 17/395356
[patent_app_country] => US
[patent_app_date] => 2021-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 19733
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17395356
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/395356 | Voltage gated sodium channel imaging agents | Aug 4, 2021 | Issued |
Array
(
[id] => 19510491
[patent_doc_number] => 20240342177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => METHODS OF TREATING BRAIN CANCER
[patent_app_type] => utility
[patent_app_number] => 18/294806
[patent_app_country] => US
[patent_app_date] => 2021-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18294806
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/294806 | METHODS OF TREATING BRAIN CANCER | Aug 3, 2021 | Pending |
Array
(
[id] => 18362718
[patent_doc_number] => 20230144309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => CRYSTALLINE FORM OF L-GLUFOSINATE AMMONIUM SALT AND PROCESS FOR PRODUCTION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/635491
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17635491
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/635491 | Crystalline form of L-glufosinate ammonium salt and process for production thereof | Jul 29, 2021 | Issued |
Array
(
[id] => 17742579
[patent_doc_number] => 11390636
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Organic solvent processable carbon phosphonitride pre-polymers
[patent_app_type] => utility
[patent_app_number] => 17/443750
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 2014
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/443750 | Organic solvent processable carbon phosphonitride pre-polymers | Jul 26, 2021 | Issued |
Array
(
[id] => 18612246
[patent_doc_number] => 20230278978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => THIOPHENE HSD17B13 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/006059
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -120
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006059
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006059 | Thiophene HSD17B13 inhibitors and uses thereof | Jul 22, 2021 | Issued |